JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sievenpiper, J. L.
Right arrow Articles by Vuksan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sievenpiper, J. L.
Right arrow Articles by Vuksan, V.
Journal of the American College of Nutrition, Vol. 23, No. 3, 248-258 (2004)
Published by the American College of Nutrition


Original Research

Decreasing, Null and Increasing Effects of Eight Popular Types of Ginseng on Acute Postprandial Glycemic Indices in Healthy Humans: The Role of Ginsenosides

John L. Sievenpiper, PhD, John T. Arnason, PhD, Lawrence A. Leiter, MD and Vladimir Vuksan, PhD

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto (J.L.S., L.A.L., V.V.), CANADA
Department of Biology, Faculty of Science, University of Ottawa, Ottawa (J.T.A.), CANADA

Address reprint requests to: Vladimir Vuksan, PhD, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, #6 138-61 Queen Street East, Toronto, Ontario, M5C 2T2, CANADA. v.vuksan{at}utoronto.ca

Background: It is unclear whether other ginseng sources can replicate the glycemic-lowering efficacy observed previously with American ginseng and whether ginsenosides are mediators. We assessed the effect of eight popular ginseng types on postprandial plasma glucose (PG) and insulin (PI) indices, linking effects to ginsenoside profiles.

Methods: Using a double-blind, randomized, multiple-crossover design, 12 healthy participants (gender: 6M:6F, age: 34 ± 3 y, BMI: 25.8 ± 1.2 kg/m2) received 10 3g treatments: American, American-wild, Asian, Asian-red, Vietnamese-wild, Siberian, Japanese-rhizome, and Sanchi ginsengs and two placebos. Each treatment was given 40-minutes before a 75g-oral-glucose-tolerance-test (75g-OGTT) with blood drawn at –40, 0, 15, 30, 45, 60, 90, 120-minutes. HPLC-UV analysis quantified seven principal ginsenosides.

Results: Two-factor analysis showed the main effects of ginseng-type and time were significant for PG and PI, with an interaction for PG (p < 0.05). Subsequent one-factor analysis showed an effect of ginseng-type on 90-min-PG and 90-min-PI (p < 0.05). This was reflected in effects on peak-PG, area under the curve (AUC)-PG and AUC-PI (p < 0.05). But the effect on 90-min-PI and AUC-PI were significant (p < 0.05) only in overweight participants (BMI > 25 kg/m2, n = 6). Planned comparisons with placebo showed a tendency for American ginseng and Vietnamese ginseng to lower 90-min-PG (p < 0.06), while Asian ginseng raised peak-PG and AUC-PG, American-wild ginseng raised 120-min-PG, and Siberian ginseng raised 90-min-PG, 120-min-PG, and AUC-PG (p < 0.05). Stepwise-multiple-regression assessed the protopanaxadiol:protopanaxatriol (PPD:PPT)-ginsenoside ratio as the sole predictor (p < 0.05) for 90-min-PG (ß = –0.43, r2 = 0.072), AUC-PG (ß = –0.25, r2 = 0.06), 90-min-PI (ß = –0.26, r2 = 0.065), AUC-PI (ß = –0.20, r2 = 0.04).

Conclusions: Ginseng has variable glycemic effects, in which the PPD:PPT-ginsenoside ratio might be involved. But the low variance explained suggests the involvement of other unmeasured ginsenoside or non-ginsenoside components.

Key words: complementary and alternative medicine, ginseng, ginsenosides, acute, postprandial, OGTT, glucose, insulin secretion, insulin sensitivity




This article has been cited by other articles:


Home page
PediatricsHome page
S. Vohra, B. C. Johnston, K. L. Laycock, W. K. Midodzi, I. Dhunnoo, E. Harris, and L. Baydala
Safety and Tolerability of North American Ginseng Extract in the Treatment of Pediatric Upper Respiratory Tract Infection: A Phase II Randomized, Controlled Trial of 2 Dosing Schedules
Pediatrics, August 1, 2008; 122(2): e402 - e410.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. L. Sievenpiper, M.-K. Sung, M. Di Buono, K. Seung-Lee, K. Y. Nam, J. T. Arnason, L. A. Leiter, and V. Vuksan
Korean Red Ginseng Rootlets Decrease Acute Postprandial Glycemia: Results from Sequential Preparation- and Dose-Finding Studies.
J. Am. Coll. Nutr., April 1, 2006; 25(2): 100 - 107.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. Buettner, G. Y Yeh, R. S Phillips, M. A Mittleman, and T. J Kaptchuk
Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors
Ann. Pharmacother., January 1, 2006; 40(1): 83 - 95.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan
North American Ginseng Exerts a Neutral Effect on Blood Pressure in Individuals With Hypertension
Hypertension, August 1, 2005; 46(2): 406 - 411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Nutrition.